Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer

<strong>Foundation:</strong> anemia constitutes one of the most frequent toxicities with intrinsic risk factors in the patient. Anemia due to toxicity due to chemotherapy is considered a single-line hematopoietic dysfunction of iatrogenic cause due to its relationship to treatment. <b...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahité Cañete Fonseca, Zaily Fuentes Díaz, Orlando Rodríguez Salazar
Format: Article
Language:Spanish
Published: Universidad de las Ciencias Médicas de Cienfuegos 2023-08-01
Series:Revista Finlay
Subjects:
Online Access:https://revfinlay.sld.cu/index.php/finlay/article/view/1274
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577382803832832
author Mahité Cañete Fonseca
Zaily Fuentes Díaz
Orlando Rodríguez Salazar
author_facet Mahité Cañete Fonseca
Zaily Fuentes Díaz
Orlando Rodríguez Salazar
author_sort Mahité Cañete Fonseca
collection DOAJ
description <strong>Foundation:</strong> anemia constitutes one of the most frequent toxicities with intrinsic risk factors in the patient. Anemia due to toxicity due to chemotherapy is considered a single-line hematopoietic dysfunction of iatrogenic cause due to its relationship to treatment. <br /><strong>Objective:</strong> to characterize the behavior of anemia due to toxicity to chemotherapy in patients with lung cancer.<strong> <br />Method:</strong> a descriptive and retrospective study was carried out in patients with lung cancer who received chemotherapy treatment at the María Curie Provincial Teaching Oncology Hospital in Camagüey province, from January 2020 to December 2022. The population under study the study consisted of 101 patients who met the inclusion criteria. The variables studied were: age, sex, staging, condition at discharge and anemia due to toxicity. Documentary analysis was used as a method, through the review of medical records.<strong> <br />Results:</strong> the male sex predominated with 73.3 % of the cases of lung cancer, there were no differences in terms of age according to sex. Most of the patients were found in stages IIIA 36.6 % and IIIB 33.6 %. 56.4 % were discharged alive and 21.8 % of the patients who received chemotherapy developed anemia due to toxicity. <br /><strong>Conclusions:</strong> the male sex predominated, most of the patients were in stages IIIA and IIIB, the highest percentage of patients were discharged alive and a considerable number of those who received chemotherapy developed anemia due to toxicity.
format Article
id doaj-art-4139fe1a02ee42839706db6fd69e285a
institution Kabale University
issn 2221-2434
language Spanish
publishDate 2023-08-01
publisher Universidad de las Ciencias Médicas de Cienfuegos
record_format Article
series Revista Finlay
spelling doaj-art-4139fe1a02ee42839706db6fd69e285a2025-01-30T21:22:02ZspaUniversidad de las Ciencias Médicas de CienfuegosRevista Finlay2221-24342023-08-01133314319652Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung CancerMahité Cañete Fonseca0Zaily Fuentes Díaz1Orlando Rodríguez Salazar2Universidad de Ciencias Médicas de Camagüey. Camaguey.Hospital Provincial Docente Oncológico María Curie. Camaguey.Hospital Universitario Manuel Ascunce Doménech. Camagüey.<strong>Foundation:</strong> anemia constitutes one of the most frequent toxicities with intrinsic risk factors in the patient. Anemia due to toxicity due to chemotherapy is considered a single-line hematopoietic dysfunction of iatrogenic cause due to its relationship to treatment. <br /><strong>Objective:</strong> to characterize the behavior of anemia due to toxicity to chemotherapy in patients with lung cancer.<strong> <br />Method:</strong> a descriptive and retrospective study was carried out in patients with lung cancer who received chemotherapy treatment at the María Curie Provincial Teaching Oncology Hospital in Camagüey province, from January 2020 to December 2022. The population under study the study consisted of 101 patients who met the inclusion criteria. The variables studied were: age, sex, staging, condition at discharge and anemia due to toxicity. Documentary analysis was used as a method, through the review of medical records.<strong> <br />Results:</strong> the male sex predominated with 73.3 % of the cases of lung cancer, there were no differences in terms of age according to sex. Most of the patients were found in stages IIIA 36.6 % and IIIB 33.6 %. 56.4 % were discharged alive and 21.8 % of the patients who received chemotherapy developed anemia due to toxicity. <br /><strong>Conclusions:</strong> the male sex predominated, most of the patients were in stages IIIA and IIIB, the highest percentage of patients were discharged alive and a considerable number of those who received chemotherapy developed anemia due to toxicity.https://revfinlay.sld.cu/index.php/finlay/article/view/1274carcinoma de pulmónquimioterapia combinadaneoplasiasmortalidadincidenciacuba
spellingShingle Mahité Cañete Fonseca
Zaily Fuentes Díaz
Orlando Rodríguez Salazar
Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
Revista Finlay
carcinoma de pulmón
quimioterapia combinada
neoplasias
mortalidad
incidencia
cuba
title Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
title_full Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
title_fullStr Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
title_full_unstemmed Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
title_short Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
title_sort behavior of anemia due to toxicity to chemotherapy in patients with lung cancer
topic carcinoma de pulmón
quimioterapia combinada
neoplasias
mortalidad
incidencia
cuba
url https://revfinlay.sld.cu/index.php/finlay/article/view/1274
work_keys_str_mv AT mahitecanetefonseca behaviorofanemiaduetotoxicitytochemotherapyinpatientswithlungcancer
AT zailyfuentesdiaz behaviorofanemiaduetotoxicitytochemotherapyinpatientswithlungcancer
AT orlandorodriguezsalazar behaviorofanemiaduetotoxicitytochemotherapyinpatientswithlungcancer